Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)-Reference-Cited by-同舟云学术

Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Published:2015-05-28 Issue:22 Volume:125 Page:3477-3483
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Gebhart Johanna¹,Posch Florian¹,Koder Silvia¹,Perkmann Thomas²,Quehenberger Peter²,Zoghlami Claudia¹,Ay Cihan¹,Pabinger Ingrid¹

Affiliation:

1. Department of Medicine I, Clinical Division of Hematology and Hemostaseology; and

2. Department of Laboratory Medicine, Division of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria

Abstract

Key PointsNew onset of thrombosis is an independent risk factor for increased mortality in LA-positive individuals. Life expectancy in our cohort of patients with LA was worse in comparison with an Austrian reference population.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/125/22/3477/1385984/3477.pdf

Reference40 articles.

1. Lupus anticoagulants and the risk of a first episode of deep venous thrombosis.;de Groot;J Thromb Haemost,2005

2. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).;Miyakis;J Thromb Haemost,2006

3. Antiphospholipid antibodies, antiphospholipid syndrome and infections.;Sène;Autoimmun Rev,2008

4. Transient lupus anticoagulants in children: stepwise disappearance of diagnostic features.;Male;Thromb Haemost,2000

5. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population.;Shi;Aust N Z J Med,1990

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation in Patients with Premature Peripheral Artery Disease Undergoing Lower Extremity Revascularization;Annals of Vascular Surgery;2024-08

2. Viewpoint: Lupus anticoagulant detection and interpretation in antiphospholipid syndrome;Rheumatology;2024-02-01

3. Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome;Seminars in Thrombosis and Hemostasis;2024-01-16

4. Risk factors of first thrombosis in obstetric antiphospholipid syndrome;Lupus Science & Medicine;2024-01

5. Comparison of different algorithms for lupus anticoagulant detection: a single-center experience;Research and Practice in Thrombosis and Haemostasis;2024-01